Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Quince Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +2 vs. Q3 2023
- Shares held
- 7.45M
- −49.6K (−0.7%) vs. Q3 2023
- Total value
- $7.83M
- −$576.1K (−6.9%) vs. Q3 2023
- New holders
- 6
- 5 more added
- Sold out
- 4
- 15 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 3,220,000 | $3.38M | 0.31% | −278,868−8.0% | Reduced |
| Vanguard Group Inc | 971,801 | $1.02M | 0.00% | +21,810+2.3% | Added |
| EPIQ Capital Group, LLC | 870,133 | $913.6K | 0.44% | −56,367−6.1% | Reduced |
| Renaissance Technologies LLC | 458,680 | $482.0K | 0.00% | +133,680+41.1% | Added |
| BlackRock Inc. | 335,604 | $352.4K | 0.00% | −838−0.2% | Reduced |
| Geode Capital Management, LLC | 261,738 | $274.9K | 0.00% | +42,135+19.2% | Added |
| Alphabet Inc. | 189,122 | $198.6K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 170,031 | $178.5K | 0.00% | −2,931−1.7% | Reduced |
| Bridgeway Capital Management, LLC | 138,495 | $145.4K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 119,741 | $125.7K | 0.00% | +43,856+57.8% | Added |
| Two Sigma Advisers, LP | 110,000 | $115.5K | 0.00% | −21,900−16.6% | Reduced |
| Susquehanna International Group, LLP | 100,078 | $105.1K | 0.00% | −3,904−3.8% | Reduced |
| Scharf Investments, LLC | 91,061 | $95.6K | 0.00% | +91,061 | New |
| Mariner, LLC | 74,074 | $77.8K | 0.00% | −1,005−1.3% | Reduced |
| Millennium Management LLC | 59,447 | $62.4K | 0.00% | −481−0.8% | Reduced |
| State Street Corp | 56,611 | $59.4K | 0.00% | 00.0% | Unchanged |
| Intellectus Partners, LLC | 53,527 | $56.2K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 43,858 | $46.1K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 21,390 | $22.5K | 0.00% | −10,550−33.0% | Reduced |
| Two Sigma Investments, LP | 13,184 | $13.8K | 0.00% | −6,461−32.9% | Reduced |
| Two Sigma Securities, LLC | 12,004 | $12.6K | 0.00% | +12,004 | New |
| Nixon Peabody Trust Co | 11,126 | $11.7K | 0.00% | +11,126 | New |
| Charles Schwab Investment Management Inc | 11,013 | $11.6K | 0.00% | 00.0% | Unchanged |
| Brinker Capital Investments, LLC | 10,136 | $11.4K | 0.00% | 00.0% | Unchanged |
| Orion Portfolio Solutions, LLC | 10,136 | $11.4K | 0.00% | 00.0% | Unchanged |
| Westmount Partners, LLC | 10,148 | $10.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 9,087 | $9.54K | 0.00% | −455−4.8% | Reduced |
| Tower Research Capital LLC (TRC) | 6,749 | $7.09K | 0.00% | +6,749 | New |
| Citigroup Inc | 5,165 | $5.42K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 2,376 | $2.50K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,264 | $1.33K | 0.00% | +52+4.3% | Added |
| Advisory Services Network, LLC | 1,050 | $1.10K | 0.00% | +1,050 | New |
| UBS Group AG | 505 | $530 | 0.00% | −6,163−92.4% | Reduced |
| JPMorgan Chase & Co | 469 | $492 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 394 | $413 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $357 | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 310 | $326 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 277 | $290 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 100 | $105 | 0.00% | −100−50.0% | Reduced |
| Financial Avengers, Inc. | 100 | $105 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $79 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 24 | $25 | 0.00% | −35−59.3% | Reduced |
| Royal Bank of Canada | 131 | $0 | 0.00% | −6−4.4% | Reduced |
| Simplex Trading, LLC | 666 | $0 | 0.00% | +666 | New |
| Strategic Blueprint, LLC | 0 | $0 | 0.00% | −12,200−100.0% | Sold out |
| Cohen Lawrence B | 0 | $0 | 0.00% | −11,126−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −267−100.0% | Sold out |
| Householder Group Estate & Retirement Specialist, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |